• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Prevalence of common chronic conditions in Medicare Advantage and traditional Medicare beneficiaries

byAdrian WongandThomas Su
February 25, 2025
in Chronic Disease, Public Health
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. In this cross-sectional study, Medicare Advantage (MA) beneficiaries had a similar prevalence of obesity, hypertension, hyperlipidemia, and chronic kidney disease compared with traditional fee-for-service Medicare beneficiaries

2. The prevalence of diabetes was higher in the MA population versus the fee-for-service Medicare population.

Evidence Rating Level: 3 (Average)

Study Rundown: The majority of Medicare beneficiaries have now been enrolled in Medicare Advantage (MA), a private plan alternative to the traditional fee-for-service (FFS) model. MA plans are paid based on risk scores that consider the health complexity of beneficiaries. Prior analyses have suggested that MA beneficiaries may have higher risk scores than FFS beneficiaries, but it is unknown whether this represents true increased medical complexity among MA beneficiaries or artificial differences caused by “upcoding” encouraged by MA payment. This study aimed to determine whether the prevalence of chronic medical conditions was higher among MA beneficiaries compared with FFS beneficiaries. Beneficiaries under MA did not have significant differences in mean body mass index (BMI), mean systolic and diastolic blood pressure, total cholesterol concentration, or estimated glomerular filtration rate (eGFR) compared with FFS beneficiaries. However, the MA cohort did on average have modestly higher HbA1c values. Sensitivity analyses showed that in participants aged 65 to 69 years, all five medical conditions studied were higher among MA beneficiaries compared with FFS beneficiaries, although the data may show a high level of uncertainty. The generalizability of this study was limited by an inability to determine differences in the severity of specific medical conditions; the limited range of medical conditions assessed; and the fact that the data assessed were older and may not reflect current realities surrounding MA. Nevertheless, these results suggested that, apart from in diabetes, there were no significant differences in the prevalence of several common medical conditions between MA beneficiaries and traditional Medicare beneficiaries.

Click to read the article in AIM

Relevant Reading: Comparing Medicare Advantage And Traditional Medicare: A Systematic Review

RELATED REPORTS

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

In-Depth [cross-sectional study]: This cross-sectional study investigated the prevalence of obesity, hypertension, hyperlipidemia, CKD, and diabetes among MA beneficiaries and FFS beneficiaries. Data were obtained from National Health and Nutrition Examination Survey (NHANES) results between 2015 and 2018. Sensitivity analyses included survey-weighted models standardized across all participant sociodemographic variables as well as analyses within specific groups, such as newer enrollees. A total of 2446 participants, consisting of 1006 MA beneficiaries and 1440 FFS beneficiaries, were included in this study. Beneficiaries under MA were more likely to be female (58.5% vs. 53.5%), less likely to be White (71.7% vs. 81.7%), less likely to have had a college education (22.4% vs. 36.4%), and more likely to have household incomes under the poverty line (11.4% vs. 7.0%) compared with FFS beneficiaries. However, the MA cohort did not have significant differences in mean BMI (29.5 kg/m2 vs. 29.3 kg/m2), mean systolic blood pressure (135.0 mm Hg vs. 134.6 mm Hg), mean diastolic blood pressure (66.4 mm Hg vs. 66.5  mm Hg), total cholesterol concentration (4.85 mmol/L vs. 4.87 mmol/L), or eGFR (75.7 mL/min/1.73 m2 vs. 73.7 mL/min/1.73 m2) compared with FFS beneficiaries. However, MA beneficiaries did have slightly higher HbA1c levels compared with FFS beneficiaries (6.1% [95% CI, 6.0% to 6.2%] vs. 6.0% [95% CI, 5.9% vs. 6.0%]). When standardized for age and sex, MA beneficiaries still did not have significant differences in the prevalence of obesity (41.1% vs. 40.6%), hypertension (70.9% vs. 71.0%), hyperlipidemia (79.4% vs. 82.3), or chronic kidney disease (19.2% vs. 22.8%) compared with FFS beneficiaries. However, the prevalence of diabetes remained higher among MA beneficiaries compared with FFS beneficiaries (33.3% vs. 26.3%). Subgroup analyses based on sociodemographic variables showed mostly similar results, except that in patients aged 65 to 69 years, the prevalence of all 5 conditions was higher among MA beneficiaries compared with FFS beneficiaries; however, the confidence intervals for this result were wide. Overall, this study suggested that, while diabetes was more prevalent among MA beneficiaries, the prevalence of several other chronic medical conditions were similar among MA beneficiaries compared to FFS beneficiaries

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseasechronic kidney disease (CKD)diabetesFFS Medicare plus Medicare AdvantagehyperlipidemiahypertensionMedicare Advantageobesity
Previous Post

Levothyroxine supplementation in pregnancy not linked to prematurity risk

Next Post

Characterization of increased cryptogenic ischemic stroke risk from smoking

RelatedReports

Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
Cost-related medication nonadherence associated with increased ED utilization
Pharma

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

September 4, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Next Post
Strict tobacco licensing laws linked to reduced adolescent smoking initiation

Characterization of increased cryptogenic ischemic stroke risk from smoking

#VisualAbstract: Addition of Aerobic Physical Activity to Resistance Exercise Does Not Improve Pain or Function in Hip Osteoarthritis

#VisualAbstract: Addition of Aerobic Physical Activity to Resistance Exercise Does Not Improve Pain or Function in Hip Osteoarthritis

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults

Maternal obesity associated with increased risk of perinatal ischemic stroke

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.